JPRN-UMIN000032875已完成未知
Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma - Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma
Kanto Neurosurgical Hospital0 个研究点目标入组 1 人开始时间: 2018年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1
研究概览
简要总结
The patient underwent SBRT at 60 Gy in 10 sequential fractions for each tumor. The biologically effective dose based on an alpha/beta ratio of 2 Gy was 240 Gy per tumor. The percentage of the total lung volume irradiated with >20 Gy was 4.9%, 3.2%, and 2.6% for each tumor.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12years-old 至 95years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The presence of other primary cancers
研究者
相似试验
已完成
不适用
CyberKnife for Unresectable Renal TumorsRenal CancerNCT00807339Beth Israel Deaconess Medical Center17
招募中
不适用
A Phase II Study of Cyberknife Radiosurgery for Renal Cell CarcinomaRenal Cell CarcinomaNCT01890590Beth Israel Deaconess Medical Center46
Unknown
3 期
CyberKnife Based Hypofractionated Radiotherapy for Vertebral HemangiomasHemangioma of Vertebral ColumnNCT02332408Maria Sklodowska-Curie National Research Institute of Oncology80
已完成
1 期
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast CancerBreast CancerNCT00872625Centre Antoine Lacassagne26
撤回
不适用
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver MetastasisColorectal CancerNCT01847495Wake Forest University Health Sciences